2025
SJR Q2
JCR Q1 · 3,4
OA
20 matched articles
ESCI
Journal detail
Clinical and Experimental Emergency Medicine
- Publisher
- Korean Society of Emergency Medicine
- Country
- South Korea · Asiatic Region
- Type
- journal
- ISSN
-
23834625
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 0,523
- Quartile Q2
- H-Index 23
- Cites/doc 2,27
- Docs (3y) 191
- Cites (3y) 381
Clarivate
Web of Science · JCR · 2025
- JCR Q Q1
- JIF 3,4
- 5Y JIF 2,2
- JCI 0,95
WoS indexes
- ESCI
Subject classification
Categories (SJR)
- Emergency Medicine Q2
- Emergency Nursing Q2
Areas
- Medicine
- Nursing
WoS categories
- Emergency Medicine
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q2 | Q1 | 0,523 | 3,4 | 2,2 | 0,95 | Q2 | 23 |
| 2024 | Q1 | Q1 | 0,632 | 2,3 | 2 | 0,97 | Q2 | 20 |
| 2023 | Q2 | Q2 | 0,47 | 1,9 | 2 | 0,72 | Q2 | 20 |
| 2022 | Q2 | — | 0,426 | 1,9 | 2 | 0,58 | Q3 | 20 |
| 2021 | Q2 | — | 0,409 | — | — | 0,6 | Q3 | 20 |
| 2020 | Q2 | — | 0,433 | — | — | 0,67 | Q2 | 20 |
| 2019 | Q2 | — | 0,335 | — | — | — | — | 20 |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | EMERGENCY MEDICINE | ESCI | Q1 | Q2 | 11/55 |
| 2024 | EMERGENCY MEDICINE | ESCI | Q1 | Q2 | 14/56 |
| 2023 | EMERGENCY MEDICINE | ESCI | Q2 | Q2 | 21/54 |
| 2022 | EMERGENCY MEDICINE | ESCI | — | Q3 | — |
| 2021 | EMERGENCY MEDICINE | ESCI | — | Q3 | — |
| 2020 | EMERGENCY MEDICINE | ESCI | — | Q2 | — |